Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
Tempus AI - RTP United States | 2 | 647 |
|
Tempus AI - CHI United States | 2 | 647 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 115 |
|
Soft Tissue Sarcoma Tumor Analysis, Fusion Detection by RT-PCR Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 12 |
|
FOXO1 (FKHR) Rearrangement Detection by FISH Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 3 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
GTC-Hematology Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 254 |
|
Clinical Genomics Laboratory Laboratory for Precision Diagnostics, University of Washington United States | 3 | 114 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Comprehensive HemeComplete Profile with IGH Somatic Hypermutation PathGroup United States | 13 | 161 |
|
PathGroup United States | 23 | 160 |
|
PathGroup United States | 18 | 160 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS PathGroup United States | 17 | 160 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 PathGroup United States | 17 | 160 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.